ES2126190T3 - Derivados de alquil-benzoilguanidina. - Google Patents

Derivados de alquil-benzoilguanidina.

Info

Publication number
ES2126190T3
ES2126190T3 ES95113104T ES95113104T ES2126190T3 ES 2126190 T3 ES2126190 T3 ES 2126190T3 ES 95113104 T ES95113104 T ES 95113104T ES 95113104 T ES95113104 T ES 95113104T ES 2126190 T3 ES2126190 T3 ES 2126190T3
Authority
ES
Spain
Prior art keywords
alkyl
opt
ch2f
substd
chf2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95113104T
Other languages
English (en)
Inventor
Rolf Dr Gericke
Manfred Dr Baumgarth
Dieter Dr Dorsch
Klaus-Otto Dr Minck
Norbert Dr Beier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2126190T3 publication Critical patent/ES2126190T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)

Abstract

ALQUIL - BENZOILGUANIDINAS DE LA FORMULA I DONDE R 1 ES A, CF{SUB, 3}, CH{SUB, 2F}, CHF{SUB, 2}, C{SUB, 2}F{SUB, 5}, CN, NO{SUB, 2}, HAL, C IDW CH O - X - R{SUP, 4}, R{SUP, 2}Y R{SUP, 3} DE FORMA INDEPENDIENTE UNO DE OTRO SIGNIFICAN H, HAL, A, - X - R{SUP, 4}, CN, NO{SUB, 2}, CF{SUB, 3}, CH{SUB, 2}F, CHF{SUB, 2}, C{SUB, 2}F{SUB, 5}, CH{SUB, 2}CF{SUB, 3}, - SO{SUB, N} - R{SUP, 6}, - SO{SUB, 2}NR{SUP, 4}R{SUP, 5}, PH, OPH O HET, R{SUP, 4} ES H, A, - CICLOALQUILO CON 5 HASTA 7 ATOMOS DE C, CICLOALQUILMETILO CON 6 HASTA 8 ATOMOS DE C, CF{SUB, 3}, CH{SUB, 2}F, CHF{SUB, 2}, CH{SUB, 2}CF{SUB, 3}, PH O - CH{SUB, 2} - PH, R{SUP, 5} ES H O A O BIEN R{SUB, 4} Y R{SUP, 5} CONJUNTAMENTE PUEDEN SER SUSTITUIDOS TAMBIEN POR ALQUILENO CON 4 HASTA 5 ATOMOS DE C, DONDE UN GRUPO CH{SUB, 2} PUEDE SER TAMBIEN REEMPLAZADO POR O, S, NH, N - A O N - CH{SUB, 2} - PH, R{SUP, 6} ES A O PH, ALK ES UN RESTO C{SUB, 1} - C{SUB, 8} - ALQUILO DE CADENA RECTA O RAMIFICADA, C{SUB, 3} - C{SUB, 8} - CICLOALQUILO, QUE PUEDE SERSUSTITUIDO 1, 2 O 3 VECES POR A O INSUSTITUIDO, - CR{SUP, 7} = CHR{SUP, 7''}; O - C IDW CR{SUP, 7}, R{SUP, 7} Y R{SUP, 7''} DE FORMA INDEPENDIENTE UNO DE OTRO SON H, A, PH, O HET, HET ES UN HETEROCICLO AROMATICO NO SATURADO O SATURADO DE UNO O DOS NUCLEOS CON 1 HASTA 4 ATOMOS DE N -, O -, Y/O S, PUDIENDO ESTAR LIGADO A TRAVES DE N O C O SER INSUSTITUIDO O SUSTITUIDO 1, 2 O 3 VECES POR HAL, CF{SUB, 3}, A, - X - R{SUB, 4}, CN, NO{SUB, 2} Y/O OXIGENO CARBOLINO. A ES ALQUILO CON 1 HASTA 6 ATOMOS DE C, HAL ES F, CL, BR, O I, X ES O, S O NR{SUP, 5}, PH ES UN FENILO INSUSTITUIDO O SUSTITUIDO 1, 2 O 3 VECES POR A, OA, NR{SUP, 4}R{SUP, 5}, F, CL, BR, I O CF{SUB, 3} Y N ES 1 O 2, ASI COMO SUS SALES TOLERABLES FISIOLOGICAMENTE, MOSTRANDO PROPIEDADES ANTIARRITMICAS Y ACTUANDO COMO INHIBIDORES DE ANTIPORTADORES NA{SUP, +}H{SUP, +} CELULARES.
ES95113104T 1994-08-31 1995-08-21 Derivados de alquil-benzoilguanidina. Expired - Lifetime ES2126190T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430916A DE4430916A1 (de) 1994-08-31 1994-08-31 Alkyl-benzoylguanidin-Derivate

Publications (1)

Publication Number Publication Date
ES2126190T3 true ES2126190T3 (es) 1999-03-16

Family

ID=6527018

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95113104T Expired - Lifetime ES2126190T3 (es) 1994-08-31 1995-08-21 Derivados de alquil-benzoilguanidina.

Country Status (20)

Country Link
US (1) US5840761A (es)
EP (1) EP0699663B1 (es)
JP (1) JP3732873B2 (es)
KR (1) KR100406687B1 (es)
CN (1) CN1055920C (es)
AT (1) ATE172962T1 (es)
AU (1) AU701558B2 (es)
BR (1) BR9503854A (es)
CA (1) CA2157143C (es)
CZ (1) CZ288015B6 (es)
DE (2) DE4430916A1 (es)
ES (1) ES2126190T3 (es)
HU (1) HU222401B1 (es)
NO (1) NO305901B1 (es)
PL (1) PL180902B1 (es)
RU (1) RU2142940C1 (es)
SK (1) SK281051B6 (es)
TW (1) TW397814B (es)
UA (1) UA41353C2 (es)
ZA (1) ZA957283B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
DE19531138A1 (de) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl-benzoylguanidin-Derivate
CA2195697A1 (en) * 1996-02-02 1997-08-03 Masahumi Kitano Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
DE19624178A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ID29523A (id) * 1998-11-26 2001-09-06 Marck Patent Gmbh Penggunaan benzoilgunidin-benzoilguanidin untuk pengobatan diabetes melitus yang tidak bergantung pada insulin
DE10001879A1 (de) * 2000-01-19 2001-07-19 Aventis Pharma Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE60329030D1 (de) * 2002-12-04 2009-10-08 Ore Pharmaceuticals Inc Melanocortin-rezeptormodulatoren
KR20060015580A (ko) * 2003-05-06 2006-02-17 메르크 파텐트 게엠베하 구아니디늄 염의 결정화 방법
USD781236S1 (en) 2016-01-14 2017-03-14 Premier Accessory Group LLC Charging device
WO2018058109A1 (en) 2016-09-26 2018-03-29 Nusirt Sciences, Inc. Compositions and methods for treating metabolic disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
ATE139526T1 (de) * 1992-02-15 1996-07-15 Hoechst Ag 3,5-substituierte benzoylguanidine, mit antiarrythmischer wirkung und inhibierender wirkung auf die proliferationen von zellen
DE59304166D1 (de) * 1992-07-01 1996-11-21 Hoechst Ag 3,4,5-Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ATE147375T1 (de) * 1992-09-22 1997-01-15 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika
TW250479B (es) * 1992-12-15 1995-07-01 Hoechst Ag
DE59306029D1 (de) * 1992-12-16 1997-05-07 Hoechst Ag 3,5-Substituierte Aminobenzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
DE4328869A1 (de) * 1993-08-27 1995-03-02 Hoechst Ag Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4417004A1 (de) * 1994-05-13 1995-11-16 Hoechst Ag Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
NO953405L (no) 1996-03-01
CZ288015B6 (cs) 2001-04-11
HU9502501D0 (en) 1995-10-30
DE4430916A1 (de) 1996-03-07
PL180902B1 (pl) 2001-04-30
CA2157143C (en) 2009-02-17
US5840761A (en) 1998-11-24
JPH08188568A (ja) 1996-07-23
CZ220395A3 (en) 1996-03-13
AU701558B2 (en) 1999-01-28
NO305901B1 (no) 1999-08-16
CA2157143A1 (en) 1996-03-01
BR9503854A (pt) 1996-09-17
NO953405D0 (no) 1995-08-30
EP0699663A1 (de) 1996-03-06
UA41353C2 (uk) 2001-09-17
EP0699663B1 (de) 1998-11-04
CN1055920C (zh) 2000-08-30
CN1128753A (zh) 1996-08-14
JP3732873B2 (ja) 2006-01-11
AU3025195A (en) 1996-02-15
KR960007538A (ko) 1996-03-22
KR100406687B1 (ko) 2004-07-19
SK105595A3 (en) 1996-03-06
HUT75094A (en) 1997-04-28
TW397814B (en) 2000-07-11
ATE172962T1 (de) 1998-11-15
PL310225A1 (en) 1996-03-04
RU2142940C1 (ru) 1999-12-20
DE59504122D1 (de) 1998-12-10
ZA957283B (en) 1996-04-02
SK281051B6 (sk) 2000-11-07
HU222401B1 (hu) 2003-06-28

Similar Documents

Publication Publication Date Title
ES2126190T3 (es) Derivados de alquil-benzoilguanidina.
PL310224A1 (en) Novel derivatives of heterocyclyl-benzoyl guanidine, method of obtaining them and pharmaceutic preparation and method of preparing same
NO306777B1 (no) 4-(anilinometylen)-2,4-dihydropyrazol-3-on-forbindelser, legemidler som består av en slik forbindelse, farmasöytiske preparater som inneholder minst én slik forbindelse, og anvendelser av forbindelsene og legemidlene til fremstilling av legemidd
DE3879264D1 (de) N-substituierte azole.
HRP20020298B1 (en) Pharmaceutical solutions of levosimendan
DK705888A (da) Pyridazinonderivater
NO306858B1 (no) Sulfonyl- eller sulfinylbenzoylguanidinderivater, farmasöytiske preparater som inneholder slike, samt anvendelse av dem til fremstilling av legemidler
NO305242B1 (no) Arylbenzoylguanidiner, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler
DK0694537T3 (da) Heterocyclyloxy-benzoylguanidinderivater, fremstilling deraf og anvendelse deraf som inhibitorer for den cellulære Na+/H+-antiporter
DE59505429D1 (de) Alkyl-5-methylsulfonyl-benzoyl-guanidin-Derivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 699663

Country of ref document: ES